119 related articles for article (PubMed ID: 1382501)
1. Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line.
Onoda N; Ohmura E; Tsushima T; Ohba Y; Emoto N; Isozaki O; Sato Y; Shizume K; Demura H
Eur J Cancer; 1992; 28A(11):1904-9. PubMed ID: 1382501
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I (IGF-I) production and the presence of IGF-I receptors in rat medullary thyroid carcinoma cell line 6-23 (clone 6).
Okimura Y; Kitajima N; Uchiyama T; Yagi H; Abe H; Shakutsui S; Chihara K
Biochem Biophys Res Commun; 1989 Jun; 161(2):589-95. PubMed ID: 2544165
[TBL] [Abstract][Full Text] [Related]
3. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.
Minuto F; Del Monte P; Barreca A; Alama A; Cariola G; Giordano G
Cancer Res; 1988 Jul; 48(13):3716-9. PubMed ID: 3378214
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a rat thyroid carcinoma cell line in vitro demonstrating high DNA synthesis in response to insulin-like growth factor I.
Nakahashi K; Kitahori Y; Konishi N; Ohnishi T; Sugimura M; Hiasa Y
Cancer Lett; 1996 Mar; 101(2):247-55. PubMed ID: 8620477
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
6. Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.
Baier TG; Jenne EW; Blum W; Schönberg D; Hartmann KK
Leuk Res; 1992 Aug; 16(8):807-14. PubMed ID: 1326686
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model.
Thompson MA; Cox AJ; Whitehead RH; Jonas HA
Endocrinology; 1990 Jun; 126(6):3033-42. PubMed ID: 1693565
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
10. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
[TBL] [Abstract][Full Text] [Related]
11. Evidence for autocrine production of IGF-1 in human thyroid adenomas.
Williams DW; Williams ED; Wynford-Thomas D
Mol Cell Endocrinol; 1989 Jan; 61(1):139-43. PubMed ID: 2744215
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.
Adamo ML; Shao ZM; Lanau F; Chen JC; Clemmons DR; Roberts CT; LeRoith D; Fontana JA
Endocrinology; 1992 Oct; 131(4):1858-66. PubMed ID: 1382963
[TBL] [Abstract][Full Text] [Related]
13. Increased activity of insulin-like growth factor-binding protein in human thyroid papillary cancer tissue.
Yashiro T; Arai M; Shizume K; Obara T; Murakami H; Hizuka N; Emoto N; Miyakawa M; Ito K; Tsushima T
Jpn J Cancer Res; 1994 Jan; 85(1):46-52. PubMed ID: 7508906
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
[TBL] [Abstract][Full Text] [Related]
15. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
16. Role of insulin-like growth factor-I in the autocrine regulation of cell growth in TT human medullary thyroid carcinoma cells.
Yang KP; Samaan NA; Liang YF; Castillo SG
Henry Ford Hosp Med J; 1992; 40(3-4):293-5. PubMed ID: 1483875
[TBL] [Abstract][Full Text] [Related]
17. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C; Silve C; Rosato R; Segovia B; Binoux M
Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
Price WA; Moats-Staats BM; Stiles AD
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I (IGF-I) antisense oligodeoxynucleotide mediated inhibition of DNA synthesis by WI-38 cells: evidence for autocrine actions of IGF-I.
Moats-Staats BM; Retsch-Bogart GZ; Price WA; Jarvis HW; D'Ercole AJ; Stiles AD
Mol Endocrinol; 1993 Feb; 7(2):171-80. PubMed ID: 7682287
[TBL] [Abstract][Full Text] [Related]
20. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver.
Long L; Nip J; Brodt P
Cancer Res; 1994 Jul; 54(14):3732-7. PubMed ID: 7518344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
